BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24022547)

  • 1. Mastectomies of healthy, contralateral breasts in patients with breast cancer.
    Basu NN; Littlechild S; Evans DG; Ross GL; Barr L
    Br J Hosp Med (Lond); 2013 Sep; 74(9):486-7. PubMed ID: 24022547
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic mastectomy and breast cancer.
    Joffe J
    Br J Hosp Med (Lond); 2013 Oct; 74(10):594-5. PubMed ID: 24273772
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic mastectomy and breast cancer-- reply.
    Basu NN; Evans DG; Barr L
    Br J Hosp Med (Lond); 2013 Oct; 74(10):595. PubMed ID: 24273773
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC; Lillquist PP; Edge SB
    Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral prophylactic mastectomy: quantifying benefits and weighing the harms.
    Helzlsouer KJ
    J Clin Oncol; 2005 Jul; 23(19):4251-3. PubMed ID: 15795414
    [No Abstract]   [Full Text] [Related]  

  • 7. Contralateral risk-reducing mastectomy in young women.
    Merck B
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():29-32. PubMed ID: 20711671
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
    Tuttle TM; Habermann EB; Virnig B
    J Natl Cancer Inst; 2010 Sep; 102(17):1371-2; author reply 1372-3. PubMed ID: 20705935
    [No Abstract]   [Full Text] [Related]  

  • 9. Contralateral prophylactic mastectomy: mind the genetics.
    Briasoulis E; Roukos DH
    J Clin Oncol; 2008 Apr; 26(11):1909-10; author reply 1910. PubMed ID: 18398162
    [No Abstract]   [Full Text] [Related]  

  • 10. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
    Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
    Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
    Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
    J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the contralateral breast.
    Kinne DW
    Ann Surg Oncol; 1994 Nov; 1(6):454-5. PubMed ID: 7850548
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.
    Narod SA
    Breast Cancer Res Treat; 2011 Jul; 128(2):581-3. PubMed ID: 21455666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic mastectomy of contralateral breast only marginally improves survival, study shows.
    Mayor S
    BMJ; 2014 Jul; 349():g4634. PubMed ID: 25035184
    [No Abstract]   [Full Text] [Related]  

  • 16. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
    Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW
    J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is family history related to preventive health behaviors and medical management in breast cancer patients?
    Madlensky L; Flatt SW; Bardwell WA; Rock CL; Pierce JP;
    Breast Cancer Res Treat; 2005 Mar; 90(1):47-54. PubMed ID: 15770526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral prophylactic mastectomy: incremental survival.
    Tanday S
    Lancet Oncol; 2014 Aug; 15(9):e369. PubMed ID: 25225695
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventive mastectomy.
    Bostwick J
    Ann Surg Oncol; 1994 Nov; 1(6):455-6. PubMed ID: 7850549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.